Zobrazeno 1 - 10
of 76
pro vyhledávání: '"M. Yair"'
Autor:
Joshua F. Zeidner, Tara L. Lin, Carlos E. Vigil, Gil Fine, M. Yair Levy, Aziz Nazha, Jordi Esteve, Daniel J. Lee, Karen Yee, Andrew Dalovisio, Eunice S. Wang, Juan M. Bergua Burgues, Jeffrey Schriber, Mark R. Litzow, Olga Frankfurt, Teresa Bernal Del Castillo, Vijaya Raj Bhatt, Bhavana Bhatnagar, Priyanka Mehta, Richard Dillon, Maria Vidriales Vicente, Stephen Anthony, David Bearss, Pau Montesinos, B. Douglas Smith
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/7122a437fe1c4abaa373b01b87a4c63e
Autor:
G. Martinelli, A. Santoro, C. Gambacorti-Passerini, S. Vives Polo, S. R. Solomon, S. Mukherjee, E. Lech-Maranda, M. Yair Levy, A. Wierzbowska, M. Calbacho-Robles, G. Marconi, M. Benedetta Giannini, I. Cano, L. Torres Miñana, E. Acuña-Cruz, N. Angelosanto, A. Galleu, S. Baldini, S. Blotta, F. Ravandi, P. Montesinos
Publikováno v:
HemaSphere, Vol 6, Pp 419-420 (2022)
Externí odkaz:
https://doaj.org/article/cc47d8a1977f48edbc17c432ee1cdf09
Autor:
Tara L. Lin, M. Yair Levy
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2012, Iss 6, Pp 205-217 (2012)
Externí odkaz:
https://doaj.org/article/a3854c5da1db425b8ab6f7891a27d78c
Autor:
Joshua F. Zeidner, Matthew C. Foster, Amanda L. Blackford, Mark R. Litzow, Lawrence E. Morris, Stephen A. Strickland, Jeffrey E. Lancet, Prithviraj Bose, M. Yair Levy, Raoul Tibes, Ivana Gojo, Christopher D. Gocke, Gary L. Rosner, Richard F. Little, John J. Wright, L. Austin Doyle, B. Douglas Smith, Judith E. Karp
Publikováno v:
Haematologica, Vol 100, Iss 9 (2015)
Serial studies have demonstrated that induction therapy with FLAM [flavopiridol (alvocidib) 50 mg/m2 days 1–3, cytarabine 667 mg/m2/day continuous infusion days 6–8, and mitoxantrone (FLAM) 40 mg/m2 day 9] yields complete remission rates of nearl
Externí odkaz:
https://doaj.org/article/a6a27ab5047644498166c8786b2628c5
Autor:
Carlos E. Vigil, Eunice S. Wang, María Belén Vidriales Vicente, Priyanka Mehta, David J. Bearss, Stephen P. Anthony, Joshua F. Zeidner, Andrew Dalovisio, Olga Frankfurt, M. Yair Levy, Richard Dillon, Mark R. Litzow, Tara L. Lin, Aziz Nazha, Pau Montesinos, Daniel J. Lee, Jeffrey Schriber, Teresa Bernal Del Castillo, Karen W.L. Yee, Jordi Esteve, Juan Miguel Bergua Burgues, Gil Fine, B. Douglas Smith, Bhavana Bhatnagar, Vijaya Raj Bhatt
Publikováno v:
Blood Cancer Journal
BLOOD CANCER JOURNAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
BLOOD CANCER JOURNAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3942dd1e54bd08a10bcfddea324cde57
http://europepmc.org/articles/PMC8557202
http://europepmc.org/articles/PMC8557202
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gerber, David E., Segal, Jodi B., Levy, M. Yair, Kane, Joyce, Jones, Richard J., Streiff, Michael B. *
Publikováno v:
In Blood 1 August 2008 112(3):504-510
Autor:
L Elizabeth Budde, Morton Coleman, Don A. Stevens, Shuo Ma, Caterina Patti, M. Yair Levy, Izidore S. Lossos, Praveen Ramakrishnan Geethakumari, Selay Lam, Roser Calvo, Kara Higgins, Paolo Strati
Publikováno v:
Journal of Clinical Oncology. 40:7549-7549
7549 Background: MZL is a rare indolent B-cell malignancy considered incurable at recurrent stage. Bruton tyrosine kinase (BTK) inhibitors have produced durable responses in patients (pts) with R/R MZL. Acalabrutinib (acala) is a potent next-generati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37268cb017bae292c2f22694ce26414b
https://doi.org/10.1200/jco.2022.40.16_suppl.7549
https://doi.org/10.1200/jco.2022.40.16_suppl.7549
Autor:
Giovanni Martinelli, Armando Santoro, Carlo Gambacorti-Passerini, Susana Vives Polo, Scott R. Solomon, Sudipto Mukherjee, M. Yair Levy, Agnieszka Wierzbowska, Maria Calbacho, Noemi Angelosanto, Antonio Galleu, Simone Baldini, Simona Blotta, Nassir Habboubi, Farhad Ravandi, Pau Montesinos
Publikováno v:
Journal of Clinical Oncology. 40:7024-7024
7024 Background: Mutations in the FLT3 tyrosine kinase are the most frequent ones that occur in adults with acute myeloid leukemia (AML) and can co-occur with mutations in IDH1 or IDH2 (collectively IDHm) in up to 30% of cases. SEL24/MEN1703 is an or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79c506e707e5ff91a38f9feca46d807f
https://doi.org/10.1200/jco.2022.40.16_suppl.7024
https://doi.org/10.1200/jco.2022.40.16_suppl.7024
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.